[HTML][HTML] Control of human toxoplasmosis

NC Smith, C Goulart, JA Hayward, A Kupz… - International journal for …, 2021 - Elsevier
Toxoplasmosis is caused by Toxoplasma gondii, an apicomplexan parasite that is able to
infect any nucleated cell in any warm-blooded animal. Toxoplasma gondii infects around 2 …

Drugs in development for toxoplasmosis: advances, challenges, and current status

PH Alday, JS Doggett - Drug design, development and therapy, 2017 - Taylor & Francis
Toxoplasma gondii causes fatal and debilitating brain and eye diseases. Medicines that are
currently used to treat toxoplasmosis commonly have toxic side effects and require …

Bisphosphonates: the first 40 years

RGG Russell - Bone, 2011 - Elsevier
The first full publications on the biological effects of the diphosphonates, later renamed
bisphosphonates, appeared in 1969, so it is timely after 40 years to review the history of their …

Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton

MJ Rogers, J Mönkkönen, MA Munoz - Bone, 2020 - Elsevier
Bisphosphonates (BP) are a class of calcium-binding drug used to prevent bone resorption
in skeletal disorders such as osteoporosis and metastatic bone disease. They act by …

Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry

A Mucha, P Kafarski, Ł Berlicki - Journal of Medicinal Chemistry, 2011 - ACS Publications
R-Aminophosphonic acids are broadly defined as analogues of amino acids in which the
carboxylic group is replaced by a phosphonic acid or related group (usually phosphonous or …

The role of the phosphorus atom in drug design

JB Rodriguez, C Gallo‐Rodriguez - ChemMedChem, 2019 - Wiley Online Library
Although the phosphorus atom is found in a variety of oxidation states, most of the
phosphorus‐containing molecules of pharmacological importance possess phosphorus in …

Biochemical and molecular mechanisms of action of bisphosphonates

MJ Rogers, JC Crockett, FP Coxon, J Mönkkönen - Bone, 2011 - Elsevier
This review describes the key discoveries over the last 15 years that have led to a clearer
understanding of the molecular mechanisms by which bisphosphonate drugs inhibit bone …

A critical review on Chagas disease chemotherapy

JR Coura, SL De Castro - Memórias do Instituto Oswaldo Cruz, 2002 - SciELO Brasil
In this" Critical Review" we made a historical introduction of drugs assayed against Chagas
disease beginning in 1912 with the works of Mayer and Rocha Lima up to the experimental …

Leishmaniasis–current chemotherapy and recent advances in the search for novel drugs

SL Croft, GH Coombs - Trends in parasitology, 2003 - cell.com
The chemotherapy currently available for leishmaniasis is far from satisfactory. Resistance to
the pentavalent antimonials, which have been the recommended drugs for the treatment of …

Metal compounds against neglected tropical diseases

YC Ong, S Roy, PC Andrews, G Gasser - Chemical reviews, 2018 - ACS Publications
Many first-line treatments for neglected tropical diseases identified by the World Health
Organization (WHO) are limited by one or more of the following: the development of drug …